Soligenix, Inc.
SNGX · NASDAQ
Bulios Fair Price
$0.18
50.5% downside
Trenutna cena
$0.36
Po podatkih Bulios Fair Price je delnica SNGX trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
Soligenix, Inc. (SNGX) is a biopharmaceutical company that focuses on the development and commercialization of drug products for the treatment of a range of diseases, including rare diseases and serious medical conditions. The company specializes in utilizing biotechnology and pharmacology for the development of therapeutic solutions. Soligenix also emphasizes research and clinical trials to confirm the efficacy and safety of its products. Their therapeutic innovations have the potential to help patients suffering from challenging-to-treat conditions. Shares of Soligenix, Inc. (SNGX) can be an interesting choice for investors tracking the biopharmaceutical sector and the development of therapeutic treatments.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Biotechnology
CEO
Christopher J. Schaber
Employees
14
Headquarters
Princeton
Prihajajoči dogodki
Earnings
Upcoming earnings report